|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 495/04 | (2006.01) |
| A61K 31/4365 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3341379 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16757513.3 |
| Date of filing the European patent application | 2016-08-22 | |
| (97) | Date of publication of the European application | 2018-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation | 2019-12-10 |
| (86) | Number | PCT/US2016/047989 |
| Date | 2016-08-22 |
| (87) | Number | WO 2017/035060 |
| Date | 2017-03-02 |
| (30) | Number | Date | Country code |
| 15382433 | 2015-08-27 | EP | |
| 15382615 | 2015-12-11 | EP |
| (72) |
DOMINGUEZ, Esteban, US
GUO, Deqi, US
MADER, Mary Margaret, US
NGUYEN, Anh-Quan Hannah, US
DEL PRADO, Miriam Filadelfa, US
RICHETT, Michael Enrico, US
RODRIGUEZ, Michael John, US
YIP, Yvonne Yee Mai, US
YU, Kuo-Long, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | EZH2 slopikliai |
| INHIBITORS OF EZH2 |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 10 | 231.00 EUR |
| 2026-08-22 |